DY-131
DY131, also known as GSK-9089, is a novel selective agonist at estrogen-related receptors ERRβ and ERRγ. DY131 could potentiate the ERRgamma-induced growth inhibition in LNCaP-ERRgamma and DU145-ERRgamma cells in a dose-dependent manner. ERRgamma may perform an antiproliferative or tumor-suppressing function in prostate cancer cells. ERRgamma could be a novel therapeutic target for prostate cancer treatment.
Product Specifications
CAS Number
95167-41-2
Product Name Alternative
DY131 | DY-131 | DY 131 | GSK-9089
Purity
>98% (HPLC)
Solubility
DMSO : 50 mg/mL. 160.58 mM
Smiles
C (=O) (c1ccc (cc1) O) N/N=C/c1ccc (cc1) N (CC) CC
Molecular Formula
C18H21N3O2
Molecular Weight
311.38
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
(E) -N'- (4- (diethylamino) benzylidene) -4-hydroxybenzohydrazide
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2521206 1.0 µg DNA
TRNAR30P sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details